Syra Health Wins New Workforce Contract, Announces Existing Contract Extension
CARMEL, Ind., Jan. 7, 2025 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA) (“Syra Health” or the “Company”), a healthcare technology company powering better health by providing meaningful solutions, announced today that the Washington D.C. government has awarded it a
Capsida Announces AbbVie Opt-in for First Genetic Medicine Program from Neurodegenerative Disease Collaboration
Capsida to receive a $40 million license payment and is eligible for additional milestones and royalties THOUSAND OAKS, Calif., Jan. 7, 2025 /PRNewswire/ — Capsida Biotherapeutics (“Capsida”) today announced that AbbVie has exercised an option for the first neurodegenerative dis
Senior Helpers Named a 2025 Top Franchise by Franchise Business Review
Independent Survey Shows Franchise Owners Are Highly Satisfied with Senior Helpers’ Support and Overall Performance TOWSON, Md., Jan. 7, 2025 /PRNewswire/ — Senior Helpers was recently named a Top Franchise for 2025 by Franchise Business Review (FBR). This is FBR’s 20th year of ho
QurAlis Invited to Present at 43rd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 7, 2025 /PRNewswire/ — QurAlis Corporation (“QurAlis”), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of amyotrophic lateral sclerosis (ALS), frontotem
Nuclein’s DASH® SARS-CoV-2 & Flu A/B Test for Use on the DASH® Rapid PCR System Receives FDA 510(k) Clearance and CLIA Waiver with Key Support from CovarsaDx® Research Team
LOS ANGELES, Jan. 7, 2025 /PRNewswire/ — CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its in vitro diagnostics (IVDs) and medical device expertise, announced today that one of its clinical research study clients, Nuclein, LLC, has received U.S. Food and Drug Admin
Nuclein’s DASH® SARS-CoV-2 & Flu A/B Test for Use on the DASH® Rapid PCR System Receives FDA 510(k) Clearance and CLIA Waiver with Key Support from CovarsaDx® Research Team
LOS ANGELES, Jan. 7, 2025 /PRNewswire/ — CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its in vitro diagnostics (IVDs) and medical device expertise, announced today that one of its clinical research study clients, Nuclein, LLC, has received U.S. Food and Drug Admin
Building Unflinching Consumer Loyalty – Sensori.Ai Reveals what Brands and Retailers Can Learn from Consumers’ Struggles with New Year’s Resolutions
The neuroscience behind how some consumers remain committed to New Year’s resolutions, and its application to building Brand and Retailer Loyalty programs. BERKELEY, Calif., Jan. 7, 2025 /PRNewswire/ — It’s the first full week of the year, and everyone is trying their best to stick
Building Unflinching Consumer Loyalty – Sensori.Ai Reveals what Brands and Retailers Can Learn from Consumers’ Struggles with New Year’s Resolutions
The neuroscience behind how some consumers remain committed to New Year’s resolutions, and its application to building Brand and Retailer Loyalty programs. BERKELEY, Calif., Jan. 7, 2025 /PRNewswire/ — It’s the first full week of the year, and everyone is trying their best to stick
Florida Cancer Specialists & Research Institute President Invited to Speak at White House Event Celebrating Cancer Moonshot and Nationwide Efforts to End Cancer
FORT MYERS, Fla., Jan. 7, 2025 /PRNewswire/ — Florida Cancer Specialists & Research Institute, LLC (FCS) President and Managing Physician Lucio N. Gordan, MD is scheduled to participate in an event today at The White House to recognize accomplishments made nationwide in accelerating progr
Florida Cancer Specialists & Research Institute President Invited to Speak at White House Event Celebrating Cancer Moonshot and Nationwide Efforts to End Cancer
FORT MYERS, Fla., Jan. 7, 2025 /PRNewswire/ — Florida Cancer Specialists & Research Institute, LLC (FCS) President and Managing Physician Lucio N. Gordan, MD is scheduled to participate in an event today at The White House to recognize accomplishments made nationwide in accelerating progr
